Publication
Consequences of disease and treatment in ANCA-associated vasculitis
Tuin, J., 2017, [Groningen]: Rijksuniversiteit Groningen. 165 p.Research output: Thesis › Thesis fully internal (DIV)

Documents
- Title and contents
Final publisher's version, 253 KB, PDF document
- Chapter 1
Final publisher's version, 563 KB, PDF document
- Chapter 2
Final publisher's version, 373 KB, PDF document
- Chapter 3
Final publisher's version, 337 KB, PDF document
- Chapter 4
Final publisher's version, 436 KB, PDF document
- Chapter 5
Final publisher's version, 426 KB, PDF document
- Chapter 6
Final publisher's version, 341 KB, PDF document
- Chapter 7
Final publisher's version, 484 KB, PDF document
- Chapter 8
Final publisher's version, 645 KB, PDF document
- Chapter 9
Final publisher's version, 432 KB, PDF document
- Chapter 10
Final publisher's version, 335 KB, PDF document
- Dankwoord
Final publisher's version, 165 KB, PDF document
- About the author
Final publisher's version, 117 KB, PDF document
- Complete thesis
Final publisher's version, 2.71 MB, PDF document
- Propositions
Final publisher's version, 33 KB, PDF document
The work in this thesis is focused on two issues regarding ANCA-associated vasculitis. In the first part, the impact of AAV on reproduction and gonadal function are investigated. In general pregnancy in vasculitis patients is considered high risk and associated with complications. We reported good outcome of pregnancy for both the mother and the child in the largest studied population up to know. Disease remission appears to be an important condition for such good outcome. Treatment with cyclophosphamide affects fertility. We have shown that with the current treatment protocols toxicity is still present, but substantially lower compared to previous protocols. Cyclophosphamide is therefore discouraged, but should not be withheld in the case of life-threatening disease. We have shown that androgen deficiency might play a role in fatigue and impaired quality of life in men with AAV.
In order to prevent damage, several treatment options to individualize and thereby optimize treatment are studied in the second part of this thesis. Trimethoprim/sulfamethoxazole and mycophenolate mofetil were studied as induction treatment for two different subgroups of AAV patients. Both treatment showed good efficacy in combination with low toxicity or side-effects. We hypothesize that glucocorticoid treatment based on individual sensitivity for glucocorticoids would improve outcome and reduces short- and long-term complications. Overall, this thesis gives insight in several consequences of disease and treatment and provides treatment options for further improvement and prevention of damage.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution | |
Supervisors/Advisors |
|
Award date | 24-May-2017 |
Place of Publication | [Groningen] |
Publisher | |
Print ISBNs | 978-94-028-0577-2 |
Electronic ISBNs | 978-94-028-0584-0 |
Publication status | Published - 2017 |
Download statistics
ID: 41953951